Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.59 |
| ▸ | PGD | P52209 | 3/20 | 0.49 |
| ▸ | PGK1 | P00558 | 1/20 | 0.44 |
| ▸ | PGK2 | P07205 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL165934 | 1.00 | MPI (0.59) | MPIPGDPGK1PGK2S1PR1 | |
| SCHEMBL2849450 | 1.00 | MPI (0.59) | MPIPGDPGK1PGK2S1PR1 | |
| SCHEMBL158926 | 1.00 | MPI (0.59) | MPIPGDPGK1PGK2S1PR1 | |
| SCHEMBL20718807 | 1.00 | MPI (0.59) | MPIPGDPGK1PGK2S1PR1 | |
| SCHEMBL23787745 | 0.89 | MPI (0.49) | MPIPGDPGK1PGK2S1PR1 | |
| SCHEMBL9078417 | 0.87 | MPI (0.45) | MPIPGD | |
| SCHEMBL2851628 | 0.86 | MPI (0.43) | MPIPGDPGK1PGK2 | |
| SCHEMBL2851632 | 0.84 | MPI (0.41) | MPIPGD | |
| SCHEMBL9937657 | 0.84 | MPI (0.49) | MPIPGDPGK1PGK2S1PR1 | |
| SCHEMBL2851638 | 0.84 | MPI (0.41) | MPIPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3279 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4743130-A1 | POLYMERIC SCAFFOLD FOR MYOCARDIAL REGENERATION AND PROTECTION | Università Degli Studi Di Torino (IT) | 2026-05-20 | — | — | EP | claimed |
| US-20260132407-A1 | VIVO SYNTHESIS OF SIALYLATED COMPOUNDS | INBIOSE N V (BE) | 2026-05-14 | — | — | US | claimed |
| WO-2026085839-A1 | COMPOSITION AND METHOD FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-04-30 | — | — | WO | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-20250277249-A1 | ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2025-09-04 | — | — | US | claimed |
| US-12378589-B2 | In vivo synthesis of sialylated compounds | INBIOSE N.V. (BE) | 2025-08-05 | — | — | US | claimed |
| CN-120025957-A | Engineering escherichia coli for synthesizing sialyl-N-tetrasaccharide a as well as construction method and application thereof | 江南大学 | 2025-05-23 | — | — | CN | claimed |
| US-20250163454-A1 | IN VITRO AND IN VIVO PROTEIN TRANSLATION VIA IN SITU CIRCULARIZED RNAS | UNIV CALIFORNIA (US) | 2025-05-22 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| EP-0970221-A1 | SELECTION METHOD FOR TRANSGENIC PLANTS | DANISCO A/S (DK) | 2000-01-12 | — | — | EP | claimed |
| EP-0739979-B1 | Glucosamine-6-phosphate deaminase and process for producing the same using a microorganism from the genus Vibrio | AGENCY IND SCIENCE TECHN (JP) | 1998-10-14 | — | — | EP | claimed |
| WO-1998035047-A1 | SELECTION METHOD FOR TRANSGENIC PLANTS | DANISCO A/S (DK) | 1998-08-13 | — | — | WO | claimed |
| WO-1998030713-A1 | PROCESS FOR PRODUCTION OF N-GLUCOSAMINE | BIO-TECHNICAL RESOURCES (US) | 1998-07-16 | — | — | WO | claimed |
| EP-0178602-B1 | TREATMENT FOR TISSUE DEGENERATIVE INFLAMMATORY DISEASE | Peritain, Ltd. (US) | 1992-05-06 | — | — | EP | claimed |
| WO-1991010912-A1 | ASSAY FOR INHERITED CONDITION | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1991-07-25 | — | — | WO | claimed |
| US-4772591-A | ASCORBIC ACID, CALCIUM SOURCE, ANTIINFLAMMATORY AGENT | PERITAIN, LTD. (US) | 1988-09-20 | — | — | US | claimed |
| US-4647453-A | Treatment for tissue degenerative inflammatory disease | PERITAIN, LTD. (US) | 1987-03-03 | — | — | US | claimed |
| US-4590067-A | BONE MEAL, ASCORBIC ACID, TYROSINE, GLUCOSAMINE, CYSTEINE | PERITAIN, LTD. (US) | 1986-05-20 | — | — | US | claimed |
| EP-0178602-A2 | Treatment for tissue degenerative inflammatory disease | Peritain, Ltd. (US) | 1986-04-23 | — | — | EP | claimed |